Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Analyzing medical and recreational cannabis state laws – a pharmacological perspective
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: FRANSON, Kari (University of Colorado, Skaggs School of Pharmacy & Pharmaceutical Sciences)
- Co-author(s): Kari L Franson
Fiona H. Wong: Skaggs School of Pharmacy & Pharmaceutical Sciences, University of Colorado, Aurora, United States
BackgroundThere are 29 states and the District of Columbia that have legalized medical, and 8 states and DC that have legalized recreational cannabis. Not all state legislatures have considered pharmacological evidence when creating their laws.
MethodsWe analyzed medical and recreational cannabis laws in these categories: age of use, approved.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 13 May 2019